Johnson & Johnson's COVID-19 vaccine may pose a "small possible risk" of a rare but potentially dangerous neurological reaction, U.S. health officials said Monday.
Johnson & Johnson's COVID-19 vaccine may pose a "small possible risk" of a rare but potentially dangerous neurological reaction, U.S. health officials said Monday.
WITH WHAT PROMPTED THE WARNING.MATT: U.S. HEALTH AT ETH SHOWS-- OFFICIALS ARE ISSUING AWARNING FOR THE JOHNSON ANDJOHNSON VACCINE BECAUSE OF THERIS SKOF A RARE NEUROLOGICALCONDITION.THE CDC SAYS ROUGHLY 100 CASESOF GUILLAIN-BARRE SYNDROMEAVE HBEEN REPORTED IN PEOPLE WHO HAVERECEIVED THE VACCINE.THE DISORDER CAN CAUSE MUSECLWEAKNESS AND EVEN PARALYSIS.NEARLY 13 MILLION SEDOS OF THEVACCINE HAVE BEEN ADMINISTEREDAND DOCTORS SAY THE RISKS SHOULDNOT BE ALARMING.
The FDA announced that they will allow Emergent Biosolutions to resume production of the Johnson and Johnson covid-19 vaccine on..
Johnson & Johnson is voluntarily recalling five Neutrogena and Aveeno brand aerosol sunscreen products after detecting a..